- According to estimates from 27 analysts, Amgen Inc. stock's average price target has risen from $352.35 to $355.04, with forecasts ranging from $200 to $427 per share
- Based on the Jul. 2 closing price, the updated target implies approximately 5% potential downside
- Consensus rating remains at “Buy” across 35 covering analysts, with 14 Buys, 17 Holds and 4 Sells
Explore more price target data and ratings for Amgen Inc. on the , and track all previous and future analyst recommendations for Amgen Inc. in the dedicated .
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.